These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11843762)
21. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal. Krieter DH; Lemke HD; Wanner C Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309 [TBL] [Abstract][Full Text] [Related]
22. Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testing. Krautzig S; Lonnemann G; Shaldon S; Koch KM Artif Organs; 1996 Jul; 20(7):798-800. PubMed ID: 8828771 [TBL] [Abstract][Full Text] [Related]
23. Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and pmma) during hemodialysis treatment using SELDI-TOF-MS. Ishikawa I; Chikazawa Y; Sato K; Nakagawa M; Imamura H; Hayama S; Yamaya H; Asaka M; Tomosugi N; Yokoyama H; Matsumoto K Am J Nephrol; 2006; 26(4):372-80. PubMed ID: 16873993 [TBL] [Abstract][Full Text] [Related]
24. Effects of novel manufacturing technology on blood and dialysate flow distribution in a new low flux "alpha Polysulfone" hemodialyzer. Gastaldon F; Brendolan A; Crepaldi C; Frisone P; Zamboni S; d'Intini V; Poulin S; Hector R; Granziero A; Martins K; Gellert R; Inguaggiato P; Ronco C Int J Artif Organs; 2003 Feb; 26(2):105-12. PubMed ID: 12653343 [TBL] [Abstract][Full Text] [Related]
25. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Pereira BJ; Snodgrass BR; Hogan PJ; King AJ Kidney Int; 1995 Feb; 47(2):603-10. PubMed ID: 7723247 [TBL] [Abstract][Full Text] [Related]
26. No evidence for endotoxin transfer across high flux polysulfone membranes. Bommer J; Becker KP; Urbaschek R; Ritz E; Urbaschek B Clin Nephrol; 1987 Jun; 27(6):278-82. PubMed ID: 3608251 [TBL] [Abstract][Full Text] [Related]
27. Easy production of sterile, pyrogen-free dialysate. Erley CM; von Herrath D; Hartenstein-Koch K; Kutschera D; Amir-Moazami B; Schaefer K ASAIO Trans; 1988; 34(3):205-7. PubMed ID: 3196509 [TBL] [Abstract][Full Text] [Related]
28. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up. Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774 [TBL] [Abstract][Full Text] [Related]
29. Cytokine production by human peripheral blood mononuclear cells stimulated by a Pseudomonas aeruginosa culture filtrate: role of plasma and polymyxin B. Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Pereira BJ Int J Artif Organs; 1996 May; 19(5):276-83. PubMed ID: 8791147 [TBL] [Abstract][Full Text] [Related]
30. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes? Kumano K; Yokota S; Nanbu M; Sakai T Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the new polyethersulfone high-flux membrane DIAPES HF800 with conventional high-flux membranes during on-line haemodiafiltration. Samtleben W; Dengler C; Reinhardt B; Nothdurft A; Lemke HD Nephrol Dial Transplant; 2003 Nov; 18(11):2382-6. PubMed ID: 14551370 [TBL] [Abstract][Full Text] [Related]
32. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods. Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S Nephron; 1997; 75(4):438-43. PubMed ID: 9127331 [TBL] [Abstract][Full Text] [Related]
33. Beta 2-microglobulin removal by synthetic dialysis membranes. Mechanisms and kinetics of the molecule. Ronco C; Heifetz A; Fox K; Curtin C; Brendolan A; Gastaldon F; Crepaldi C; Fortunato A; Pietribasi G; Caberlotto A; Brunello A; Milan Manani S; Zanella M; La Greca G Int J Artif Organs; 1997 Mar; 20(3):136-43. PubMed ID: 9151148 [TBL] [Abstract][Full Text] [Related]
34. In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma. Geremia I; Bansal R; Stamatialis D Acta Biomater; 2019 May; 90():100-111. PubMed ID: 30953798 [TBL] [Abstract][Full Text] [Related]
35. Transfer of endogenous pyrogens across artificial membranes? Lonnemann G; Linnenweber S; Burg M; Koch KM Kidney Int Suppl; 1998 May; 66():S43-6. PubMed ID: 9573572 [TBL] [Abstract][Full Text] [Related]
36. Ultrafiltration and endotoxin removal from dialysis fluids. Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921 [TBL] [Abstract][Full Text] [Related]
37. Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. Lonnemann G Kidney Int Suppl; 1993 Jun; 41():S195-200. PubMed ID: 8320919 [No Abstract] [Full Text] [Related]